On September 20, 2019 Mallinckrodt Pharmaceuticals (NYSE: MNK), a global biopharmaceutical company, reported that it will present at the Cantor Global Healthcare Conference at the InterContinental New York Barclay, 111 E. 48th St., New York on Wednesday, Oct. 2, 2019 (Press release, Mallinckrodt, SEP 20, 2019, View Source [SID1234539676]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mark Trudeau, President and Chief Executive Officer, and Steven Romano, M.D., Executive Vice President and Chief Scientific Officer, will represent the company in a fireside chat at 4:10 p.m. Eastern.

Individuals who cannot attend the meeting in person can find webcast information at: http://www.mallinckrodt.com/investors. A replay also will be available following the meeting.